Keywords: پاسخ هدف; Stereotyping; Implicit association test; Warmth; Competence; Objective response;
مقالات ISI پاسخ هدف (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پاسخ هدف; Metastatic kidney cancer; Multiple lines of treatment; Objective response; Survival; Targeted therapy
Keywords: پاسخ هدف; Head and neck squamous cell carcinoma; ERCC1; Cisplatin-based concurrent chemoradiotherapy; Objective response; Survival;
Keywords: پاسخ هدف; Streptozocin; 5-Fluorouracil; Pancreatic neuroendocrine tumour; Ki-67; Chemotherapy; Pancreas; Neuroendocrine tumour; Objective response; Survival;
Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy
Keywords: پاسخ هدف; AE; adverse event; ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; CR; complete response; ECOG; Eastern Cooperative Oncology Group; EGFR; epidermal growth factor receptor; HR; hazar
Allogeneic Hematopoietic Cell Transplantation for Richter Syndrome: A Single-Center Experience
Keywords: پاسخ هدف; Chronic lymphocytic leukemia transformation; Nonrelapse mortality; Objective response; Overall survival; Relapse/progression;
Gene Signature Associated with Upregulation of the Wnt/β-Catenin Signaling Pathway Predicts Tumor Response to Transarterial Embolization
Keywords: پاسخ هدف; HCC; hepatocellular carcinoma; OR; objective response; RFE; recursive feature elimination; SVM; support vector machine;
Korean Multicenter Registry of Transcatheter Arterial Chemoembolization with Drug-Eluting Embolic Agents for Nodular Hepatocellular Carcinomas: Six-Month Outcome Analysis
Keywords: پاسخ هدف; BCLC; Barcelona Clinic Liver Cancer; CR; complete response; DEE; drug-eluting embolic; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular carcinoma; IDR; intrahepatic distant recurrence; LTP; local tumor progression; PFS; progression-free survi
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC
Keywords: پاسخ هدف; Liver cancer; Carcinoma, hepatocellular; Advanced BCLC; Brivanib, mRECIST; Objective response; Surrogate end-point; Response evaluation criteria in solid tumours;
Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase
Keywords: پاسخ هدف; Low-grade serous ovarian cancer; High-grade serous ovarian cancer; Platinum chemotherapy; Objective response
Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT)
Keywords: پاسخ هدف; CI; confidence interval; EASL; European Association for the Study of Liver; ICC; intrahepatic cholangiocarcinoma; OR; objective response; OS; overall survival; RECIST; Response Evaluation Criteria in Solid Tumors; SIRT; Yttrium-90 glass microspheres selec
Baseline and Early MR Apparent Diffusion Coefficient Quantification as a Predictor of Response of Unresectable Hepatocellular Carcinoma to Doxorubicin Drug-Eluting Bead Chemoembolization
Keywords: پاسخ هدف; ADC; apparent diffusion coefficient; AUC; area under the curve; CR; complete response; DEB; drug-eluting bead; DWI; diffusion-weighted imaging; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; LRT; locoregional therapy
Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials
Keywords: پاسخ هدف; Sunitinib; Objective response; Metastatic renal cell carcinoma;
Early Response to Chemotherapy in Patients With Non–Small-Cell Lung Cancer Assessed by [18F]-Fluoro-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography
Keywords: پاسخ هدف; Antiangiogenic therapy; First-line treatment; Objective response; Positron emission tomography (PET); Sorafenib
Response Evaluation Criteria in Solid Tumors (RECIST) Criteria Are Superior to European Association for Study of the Liver (EASL) Criteria at 1 Month Follow-up for Predicting Long-term Survival in Patients Treated with Transarterial Chemoembolization befo
Keywords: پاسخ هدف; EASL; European Association for Study of the Liver; HCC; hepatocellular carcinoma; LT; liver transplantation; NR; no response; OR; objective response; RECIST; Response Evaluation Criteria in Solid Tumors; TTP; time to progression; TTR; time to response;
Les anticorps conjugués en oncologie : du concept au trastuzumab emtansine (T-DM1)
Keywords: پاسخ هدف; trastuzumab emtansine; cancer du sein HER2-positif; réponse objective; bénéfice clinique; tolérance; trastuzumab emtansine; HER2-positive breast cancer; objective response; clinical benefit; safety;
Serum anti-p53 antibody detection in carcinomas and the predictive values of serum p53 antibodies, carcino-embryonic antigen and carbohydrate antigen 12-5 in the neoadjuvant chemotherapy treatment for III stage non-small cell lung cancer patients
Keywords: پاسخ هدف; s-p53 Abs; serum p53 antibodies; wt; wild-type; NACT; neoadjuvant chemotherapy; SQ; SQAMDDLMLS; NSCLC; non-small cell lung cancer; CEA; carcino-embryonic antigen; CA12-5; carbohydrate antigen 12-5; MVC; mitomycin, vindesine and cisplatin; STBM; serum tu
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
Keywords: پاسخ هدف; Advanced gastric cancer; Sunitinib; Tyrosine kinase inhibitor; Objective response; Biomarkers;
Complete response by a combination of 5-fluorouracil and interferon-α chemotherapy for lung metastasis of hepatocellular carcinoma after hepatic resection with portal and hepatic vein tumor thrombectomy
Keywords: پاسخ هدف; AFP; alpha fetoprotein; CT; computed tomography; FdUMP; fluorodeoxyuridine monophosphate; 5FU; 5-fluorouracil; HCC; hepatocellular carcinoma; IFN-α; interferon-α; OR; objective response; PIVKA-II; protein induced by Vitamin K absence or antagonist II; P